secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001493152-24-042911
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Elizabeth Ng takes sabbatical; Director M. Michelle Berrey appointed Interim CEO
--------------------------------------------------------------------------------

- Elizabeth Ng notified Board on Oct 23, 2024 of sabbatical for personal reasons.
- Director M. Michelle Berrey appointed Interim CEO, effective immediately.
- Compensation arrangements for Interim CEO not yet determined; will be disclosed later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/0001493152-24-042911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer